{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:12:03Z","timestamp":1778645523669,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA 75977"],"award-info":[{"award-number":["R01 CA 75977"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA 47749"],"award-info":[{"award-number":["R01 CA 47749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K05 CA 92002"],"award-info":[{"award-number":["K05 CA 92002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ajog.2004.04.041","type":"journal-article","created":{"date-parts":[[2004,10,23]],"date-time":"2004-10-23T23:05:56Z","timestamp":1098572756000},"page":"1146-1151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer"],"prefix":"10.1016","volume":"191","author":[{"given":"Susan D.","family":"Reed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda F.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley A.A.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.04.041_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.04.041_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(96)07365-5","article-title":"Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestogen therapy in postmenopausal women","volume":"349","author":"Beresford","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.04.041_bib3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1067\/mob.2000.108081","article-title":"Continuous combined hormone replacement therapy and risk of endometrial cancer","volume":"183","author":"Hill","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.04.041_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/89.15.1110","article-title":"Estrogen-progestin replacement therapy and endometrial cancer","volume":"89","author":"Pike","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2004.04.041_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2004.04.041_bib6","first-page":"195","article-title":"Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)","volume":"14","author":"Newcomb","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2004.04.041_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0895-4356(99)00192-4","article-title":"Hormone replacement therapy and endometrial cancer in Ontario, Canada","volume":"53","author":"Jain","year":"2000","journal-title":"J Clin Epi"},{"key":"10.1016\/j.ajog.2004.04.041_bib8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures in the Women's Health Initiative: a randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.04.041_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1047-2797(01)00274-5","article-title":"The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results","volume":"12","author":"Marchbanks","year":"2002","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2004.04.041_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/01621459.1978.10479995","article-title":"Sampling methods for random digit dialing","volume":"73","author":"Waksberg","year":"1978","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ajog.2004.04.041_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/oxfordjournals.aje.a115313","article-title":"Pictorially assisted recall of past hormone use in case-control studies","volume":"130","author":"Beresford","year":"1989","journal-title":"Am J Epidem"},{"key":"10.1016\/j.ajog.2004.04.041_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/oxfordjournals.aje.a113386","article-title":"Reliability of recall of drug usage and other health-related information","volume":"116","author":"Paganini-Hill","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.04.041_bib13","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee","volume":"854","author":"Writing Group for the World Health Organization","year":"1995","journal-title":"World Health Organ"},{"key":"10.1016\/j.ajog.2004.04.041_bib14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/oxfordjournals.aje.a009759","article-title":"Logistic regression analysis for more than one characteristic of exposure","volume":"149","author":"McKnight","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.04.041_bib15","series-title":"The analysis of case control studies Vol 1","author":"Breslow","year":"1980"},{"key":"10.1016\/j.ajog.2004.04.041_bib16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9378(13)90437-3","article-title":"Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone","volume":"170","author":"Woodruff","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.04.041_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198112313052701","article-title":"Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium","volume":"305","author":"Whitehead","year":"1981","journal-title":"NEJM"},{"key":"10.1016\/j.ajog.2004.04.041_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.04.041_bib19","first-page":"982","article-title":"Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen\/Progestin Trial","volume":"92","author":"Greendale","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.04.041_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/3.2.159","article-title":"Progestogen intolerance and compliance with hormone replacement therapy in menopausal women","volume":"3","author":"Panay","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2004.04.041_bib21","first-page":"270","article-title":"Adherence to postmenopausal hormone therapy during the year after the initial prescription: a population-based study","volume":"182","author":"Hill","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.04.041_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women","volume":"273","author":"Writing Group for the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.04.041_bib23","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O","article-title":"Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women","volume":"88","author":"Li","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2004.04.041_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2004.04.041_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.284.6.691-f","article-title":"Estrogen-progestin replacement and risk of breast cancer","volume":"284","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.04.041_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/cmt.4.2.110.119","article-title":"Is low dose hormone replacement therapy for postmenopausal women efficacious and desirable?","volume":"4","author":"Lobo","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.ajog.2004.04.041_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated estrogens and medroxyprogesterone acetate","volume":"65","author":"Utian","year":"2001","journal-title":"Fertil Steril"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804004600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804004600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:39:05Z","timestamp":1778643545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937804004600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0002937804004600"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.04.041","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}